NDC 61133-5442-4 - NeoMed 325
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 61133-5442
- Requested NDC
- 61133-5442-4
- Package NDCs from labels
- 61133-5442-2, 61133-5442-3, 61133-5442-4
- Manufacturer
- Bimeda, Inc.
- Effective date
- 2024-03-28
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| NeoMed 325 - Bimeda, Inc. | Bimeda, Inc. | 2024-03-28 | PRESCRIPTION ANIMAL DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 61133-5442-2 | NeoMed 325 | 22.7 kg in 1 PAIL | POWDER, FOR SOLUTION | 22.7 | 14 | |
| 61133-5442-3 | NeoMed 325 | 0.2 kg in 1 POUCH | POWDER, FOR SOLUTION | 0.2 | 14 | |
| 61133-5442-4 | NeoMed 325 | 0.1 kg in 1 POUCH | POWDER, FOR SOLUTION | 0.1 | 14 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 61133-5442 | NEOMED 325 (NEOMYCIN SULFATE) POWDER, FOR SOLUTION [BIMEDA, INC.] | 14 | 3 package rows | 20240329_12264d46-0eb5-4a2d-a972-4230ed4fd771.zip |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| NEOMYCIN SULFATE | ACTIVE INGREDIENT | 057Y626693 | NEOMED 325 (NEOMYCIN SULFATE) POWDER, FOR SOLUTION [BIMEDA, INC. DIVISION OF CROSS VETPHARM GROUP] | 7 | |
| Neomycin | ACTIVE MOIETY | I16QD7X297 | NEOMED 325 (NEOMYCIN SULFATE) POWDER, FOR SOLUTION [BIMEDA, INC. DIVISION OF CROSS VETPHARM GROUP] | 7 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Neomycin Polymyxin B Sulfates and Dexamethasone | NEOMYCIN SULFATE, POLYMYXIN B SULFATE AND DEXAMETHASONE | Sportpharm LLC | d35d9fbb-4dd6-4565-9d5a-a14ceaafc021 | 2026-10-31 | Warnings, Adverse reactions | 057Y626693 |
| Triple Antibiotic First Aid Antibiotic | BACITRACIN ZINC, NEOMYCIN AND POLYMYXIN B SULFATE | Savvy Care & Cosmetics Pvt. Ltd. | 5f1fcf7b-497d-e035-e063-6394a90a6956 | 2026-10-31 | Warnings | 057Y626693 |
| First Aid Only Triple Antibiotic | BACITRACIN ZINC, NEOMYCIN SULFATE, POLYMYXIN B SULFATE | Acme United Corporation | 5d6a7cd2-a2f3-c8a1-e063-6394a90a6ba0 | 2026-10-29 | Warnings | 057Y626693 |
| Triple Antibiotic | BACITRACIN ZINC, NEOMYCIN SULFATE, AND POLYMYXIN B SULFATE | Sun Pharmaceutical Industries, Inc. | d77239e6-5e81-439a-b0cd-f8be59169442 | 2026-10-26 | Warnings | 057Y626693 |
| Medpride First Aid | BACITRACIN ZINC NEOMYCIN SULFATE POLYMYXIN B SULFATE | Shield Line LLC | 5ba3e703-7873-4724-a0bf-bb22d8a25748 | 2026-10-23 | Warnings | 057Y626693 |
| Good Sense First Aid Antibiotic | BACITRACIN ZINC, NEOMYCIN, POLYMYXIN B | Preferred Pharmaceuticals Inc. | ac5b585c-050d-44a2-80d2-642597dc8892 | 2026-10-19 | Warnings | 057Y626693 |
| Triple Antibiotic | BACITRACIN ZINC, NEOMYCIN SULFATE, POLYMYXIN B SULFATE, POLYMYXIN B | J&A Digital Inc. | 9b8f2046-5886-440d-a7fc-a71138d7f34b | 2026-10-16 | Warnings | 057Y626693 |
| Triple Antibiotic | BACITRACIN ZINC, NEOMYCIN SULFATE, POLYMYXIN B SULFATE | J&A Digital Inc. | 9f006f16-083d-4e95-aec2-6ef83405f393 | 2026-10-16 | Warnings | 057Y626693 |
| TRIPLE ANTIBIOTIC PLUS PAIN RELIEF | BACITRACIN ZINC, NEOMYCIN SULFATE, POLYMYXIN B SULFATE, AND PRAMOXINE HYDROCHLORIDE | GENOMMA LAB USA, INC. | 506fcda5-df44-49c8-8dbd-cab7434b06b2 | 2026-10-14 | Warnings | 057Y626693 |
| Neomycin and Polymyxin B sulfates and Hydrocortisone OTIC | NEOMYCIN AND POLYMYXIN B SULFATES AND HYDROCORTISONE | Orbicular Pharmaceutical Technologies Private Limited | 5eae31aa-ec63-4b93-9859-8d718a8ac8ef | 2026-10-14 | Warnings, Adverse reactions | 057Y626693 |
| EQUATE Triple Antibiotic | BACITRACIN ZINC, NEOMYCIN SULFATE, POLYMYXIN B SULFATE | Wal-Mart Stores Inc | fa35f446-6a58-4d8c-859e-89cd631a9e8f | 2026-10-08 | Warnings | 057Y626693 |
| Bacitracin Zinc, Neomycin Sulfate, and Polymyxin B Sulfate | BACITRACIN ZINC, NEOMYCIN SULFATE, AND POLYMYXIN B SULFATE | Henry Schein | ead9496b-112e-59e6-e053-2995a90a768c | 2026-10-07 | Warnings | 057Y626693 |
| Bacitracin Zinc, Polymyxin B Sulfate, and Neomycin Sulfate | BACITRACIN ZINC, POLYMYXIN B SULFATE, AND NEOMYCIN SULFATE | Henry Schein | eadb847e-aefe-41cf-e053-2995a90af2cd | 2026-10-07 | Warnings | 057Y626693 |
| DG Health Triple Antibiotic | BACITRACIN ZINC, NEOMYCIN, POLYMYXIN B | Dolgencorp, LLC | 1694f4ee-1065-4b13-b642-b8437f473541 | 2026-10-07 | Warnings | 057Y626693 |
| neomycin sulfate, polymyxin b sulfate and dexamethasone | NEOMYCIN SULFATE, POLYMYXIN B SULFATE AND DEXAMETHASONE | Nordic Pharma, Inc. | 191c1a56-194f-4876-b501-2f8aee447d83 | 2026-10-05 | Warnings, Adverse reactions | 057Y626693 |
| Good Neighbor Pharmacy Triple Antibiotic Plus Pain Relief | BACITRACIN ZINC, NEOMYCIN SULFATE, POLYMYXIN B SULFATE, AND PRAMOXINE HYDROCHLORIDE | Amerisource Bergen | 4ed52cb6-75aa-41ed-ba65-fb9dce2e4b46 | 2026-09-25 | Warnings | 057Y626693 |
| Triple Antibiotic | BACITRACIN ZINC, NEOMYCIN SULFATE, AND POLYMYXIN B SULFATE | AmerisourceBergen | f3c9b5cf-790a-46c6-94eb-4f866deac1e5 | 2026-09-25 | Warnings | 057Y626693 |
| bacitracin zinc, neomycin sulfate and polymyxin b sulfate | BACITRACIN ZINC, NEOMYCIN SULFATE AND POLYMYXIN B SULFATE | Dynarex Corporation | 96d06e4c-c9e7-446f-8b2d-5d030e51d3d3 | 2026-09-23 | Warnings | 057Y626693 |
| berkley and jensen triple antibiotic | BACITRACIN ZINC, NEOMYCIN, POLYMYXIN B | BJWC | e81d32cb-4512-4b25-8d63-e3335e8e8ecf | 2026-09-17 | Warnings | 057Y626693 |
| First Aid Only Triple Antibiotic | BACITRACIN ZINC, NEOMYCIN SULFATE, POLYMYXIN B SULFATE | Acme United Corporation | 5b7621c9-1515-815d-e063-6294a90aed25 | 2026-09-14 | Warnings | 057Y626693 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.